Study of Triostat in Infants During Heart Surgery

• Status: Completed
• Trial end date: 2007-08-01

Summary

This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.

• Phase: Phase 3

Details

• Lead Sponsor: Michael Portman